peplexicon
Choose your depth

Context, anatomy, and key evidence

← Peptide library

muscle-relax peptide

Vialox

Published evidence · coverage incomplete
Anatomical contextAnatomy connections are not mapped yet.

No body region is highlighted until this profile has a supported anatomical connection. This does not mean the peptide has no biological effects.

Read published mechanism findings ↓

At a glance

What is it—and why does it matter?

Vialox is defined here by its amino-acid sequence: Gly‑Pro‑Arg‑Pro‑Ala (a pentapeptide).

Sources for this introduction: [1]

This published profile is a reference in progress. Findings retain their source context; missing topics are marked below.

What is it?

A molecule, not a product name.

Identity

Vialox is defined here by its amino-acid sequence: Gly‑Pro‑Arg‑Pro‑Ala (a pentapeptide).

Sources[1]pubmedIn Vitro and In Silico Assessment of Anticancer Activity of Venom-Derived and Biomimetic Neurotransmitter Inhibitor Pentapeptides.Vialox (Gly-Pro-Arg-Pro-Ala) derived from Tropidolaemus wagleri venom[1]pubmedIn Vitro and In Silico Assessment of Anticancer Activity of Venom-Derived and Biomimetic Neurotransmitter Inhibitor Pentapeptides.Vialox (Gly-Pro-Arg-Pro-Ala)
Source records
2
Independent studies
1

Evidence boundary: Applies only to the source-defined population, formulation, dose, and assessment period.

Exact passages, locators, and provenance
  1. supports · Source-backed record
    “Vialox (Gly-Pro-Arg-Pro-Ala) derived from Tropidolaemus wagleri venom”

    In Vitro and In Silico Assessment of Anticancer Activity of Venom-Derived and Biomimetic Neurotransmitter Inhibitor Pentapeptides. · Abstract

    pubmed:42412310:fc1c7638d8fc:fc1c7638d8fc
  2. supports · Source-backed record
    “Vialox (Gly-Pro-Arg-Pro-Ala)”

    In Vitro and In Silico Assessment of Anticancer Activity of Venom-Derived and Biomimetic Neurotransmitter Inhibitor Pentapeptides. · Abstract

    pubmed:42412310:fc1c7638d8fc:fc1c7638d8fc

How does it work?

Target, response, and disposition.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

What has been studied?

What the evidence says.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Risks and interactions

Risks, organized for scanning.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Products and regulatory status

Same ingredient. Different records.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Administration context

The practical clinical context.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Research status + gaps

What still needs better answers?

  • No publishable claim yet for: administration, contraindication, effect, interaction, mechanism, regulatory, safety
  • 12 compiled claim(s) withheld by automated assurance: assurance_score_below_0.58 (11), assurance_score_below_0.72 (1), extraction_ambiguity (12), high_risk_requires_regulatory_or_two_independent_sources (1), no_direct_support (12)

These are the limits of this profile, not an exhaustive list of scientific uncertainties.

References + discovery

Open the records yourself.

  1. In Vitro and In Silico Assessment of Anticancer Activity of Venom-Derived and Biomimetic Neurotransmitter Inhibitor Pentapeptides. ↗

    pubmed · published 2026-07-07 · retrieved 2026-08-27T11:48:55Z

Publication history and provenance

Version 2 · Automated assessment · 2026-08-27T11:48:55Z

f708218809b6bfcae780bd147aa493ca98b4dce29fbdca1f8214919f73ffab0c